We do not publish a verdict for Accendra Health Inc (ACH) and EDAP TMS SA ADR (FOCL) is overvalued.
We publish an intrinsic value for FOCL but not for ACH, so the two cannot be ranked on price.
Values as of the 22 Sept 2026 close.
We do not publish a value for this company: its projected cash flows are negative in every year, including the terminal one.
Leak Score 0/100 on 1 of 12 signals
A 1.5x revenue multiple, discounted for its losses, values the shares at $2.24; the price of $4.27 is 91% above that value.
Leak Score 0/100 on 2 of 12 signals
| Metric | ACH | FOCL |
|---|---|---|
| Verdict | Not valued | Overvalued |
| Price | $0.85 | $4.27 |
| Intrinsic value | — | $2.24 |
| Margin of safety | — | -91% |
| Leak Score | 0/100 (1/12) | 0/100 (2/12) |
| Market cap | $65M | $160M |
| Revenue growth, 5 years | -20.1% | 8.3% |
| Operating margin | 1.4% | -39.3% |
| Net margin | -11.4% | -56.3% |
| Return on equity | -198.3% | -263.8% |
| Forward P/E | 4.7x | — |